Efficacy and safety of daclatasvir-containing regimens in the treatment of chronic hepatitis C patients in Damietta

• Үндсэн зохиолчид: Alaa Eldeen M Hashim (Зохиогч), Samy Zaky (Зохиогч), Magdy Z Alghannam (Зохиогч), Sabry A Ibraheem (Зохиогч), Fathiya M El-Raey (Зохиогч), Ahmed Abdelaziz (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background Chronic hepatitis C virus infection is one of the most important health problems in Egypt. Since November 2015, generic sofosbuvir (SOF) with daclatasvir (DCV)±ribavirin (RBV) became the standard treatment in all National Committee for Control of Viral Hepatitis centers. Yet, the long-ter...